#ESMO26 🚀 HARMONi-GI1 | Phase III

🇨🇳 682 pts | 1L advanced BTC
💊 Ivonescimab+GemCis vs Durva+GemCis

🏆 OS: 14.9 vs 12.1 mo (HR 0.75)
📈 PFS: 8.4 vs 5.8 mo (HR 0.61)
🎯 ORR: 53.8% vs 32.5%

⚠️ G3–4 AEs: 82% vs 72.3%

💡 Potential new 1L SoC

@OncoAlert